These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
233 related articles for article (PubMed ID: 20884630)
61. Relevance of the chaperone-like protein calreticulin for the biological behavior and clinical outcome of cancer. Fucikova J; Kasikova L; Truxova I; Laco J; Skapa P; Ryska A; Spisek R Immunol Lett; 2018 Jan; 193():25-34. PubMed ID: 29175313 [TBL] [Abstract][Full Text] [Related]
63. Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells. Hsu FJ; Benike C; Fagnoni F; Liles TM; Czerwinski D; Taidi B; Engleman EG; Levy R Nat Med; 1996 Jan; 2(1):52-8. PubMed ID: 8564842 [TBL] [Abstract][Full Text] [Related]
64. Dendritic cells combined with doxorubicin induces immunogenic cell death and exhibits antitumor effects for osteosarcoma. Kawano M; Tanaka K; Itonaga I; Iwasaki T; Miyazaki M; Ikeda S; Tsumura H Oncol Lett; 2016 Mar; 11(3):2169-2175. PubMed ID: 26998143 [TBL] [Abstract][Full Text] [Related]
65. Immunogenic tumor cell death induced by chemoradiotherapy: molecular mechanisms and a clinical translation. Kono K; Mimura K; Kiessling R Cell Death Dis; 2013 Jun; 4(6):e688. PubMed ID: 23788045 [TBL] [Abstract][Full Text] [Related]
66. Sourcing the immune system to induce immunogenic cell death in Kras-colorectal cancer cells. Cirone M; Lotti LV; Granato M; Renzo LD; Biunno I; Cattaneo M; Verginelli F; Vespa S; Davies D; Wells V; Mariani-Costantini R; Mallucci L Br J Cancer; 2019 Oct; 121(9):768-775. PubMed ID: 31558803 [TBL] [Abstract][Full Text] [Related]
67. Calreticulin exposure by malignant blasts correlates with robust anticancer immunity and improved clinical outcome in AML patients. Fucikova J; Truxova I; Hensler M; Becht E; Kasikova L; Moserova I; Vosahlikova S; Klouckova J; Church SE; Cremer I; Kepp O; Kroemer G; Galluzzi L; Salek C; Spisek R Blood; 2016 Dec; 128(26):3113-3124. PubMed ID: 27802968 [TBL] [Abstract][Full Text] [Related]
68. The marine natural product mimic MPM-1 is cytolytic and induces DAMP release from human cancer cell lines. von Hofsten S; Paulsen MH; Magnussen SN; Ausbacher D; Kranz M; Bayer A; Strøm MB; Berge G Sci Rep; 2022 Sep; 12(1):15586. PubMed ID: 36114339 [TBL] [Abstract][Full Text] [Related]
69. Nanosecond-Pulsed DBD Plasma-Generated Reactive Oxygen Species Trigger Immunogenic Cell Death in A549 Lung Carcinoma Cells through Intracellular Oxidative Stress. Lin A; Truong B; Patel S; Kaushik N; Choi EH; Fridman G; Fridman A; Miller V Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28467380 [TBL] [Abstract][Full Text] [Related]
70. Fifteen-year follow-up of relapsed indolent non-Hodgkin lymphoma patients vaccinated with tumor-loaded dendritic cells. Fucà G; Ambrosini M; Agnelli L; Brich S; Sgambelluri F; Mortarini R; Pupa SM; Magni M; Devizzi L; Matteucci P; Cabras A; Zappasodi R; De Santis F; Anichini A; De Braud F; Gianni AM; Di Nicola M J Immunother Cancer; 2021 Jun; 9(6):. PubMed ID: 34127544 [TBL] [Abstract][Full Text] [Related]
71. [The Concept of Immunogenic Cell Death in Antitumor Immunity]. Fučíková J; Bartůňková J; Špíšek R Klin Onkol; 2015; 28 Suppl 4():4S48-55. PubMed ID: 26647889 [TBL] [Abstract][Full Text] [Related]
72. CD40-activated B cell cancer vaccine improves second clinical remission and survival in privately owned dogs with non-Hodgkin's lymphoma. Sorenmo KU; Krick E; Coughlin CM; Overley B; Gregor TP; Vonderheide RH; Mason NJ PLoS One; 2011; 6(8):e24167. PubMed ID: 21904611 [TBL] [Abstract][Full Text] [Related]
73. Immunogenic Apoptotic Cell Death and Anticancer Immunity. Vandenabeele P; Vandecasteele K; Bachert C; Krysko O; Krysko DV Adv Exp Med Biol; 2016; 930():133-49. PubMed ID: 27558820 [TBL] [Abstract][Full Text] [Related]
74. Calreticulin exposure dictates the immunogenicity of cancer cell death. Obeid M; Tesniere A; Ghiringhelli F; Fimia GM; Apetoh L; Perfettini JL; Castedo M; Mignot G; Panaretakis T; Casares N; Métivier D; Larochette N; van Endert P; Ciccosanti F; Piacentini M; Zitvogel L; Kroemer G Nat Med; 2007 Jan; 13(1):54-61. PubMed ID: 17187072 [TBL] [Abstract][Full Text] [Related]
75. Ex vivo photothermal treatment-induced immunogenic cell death for anticancer vaccine development. Yu SH; Yoon I; Kim YJ Int Immunopharmacol; 2024 Jan; 127():111450. PubMed ID: 38157695 [TBL] [Abstract][Full Text] [Related]
76. Leveraging the immune system during chemotherapy: moving calreticulin to the cell surface converts apoptotic death from "silent" to immunogenic. Obeid M; Panaretakis T; Tesniere A; Joza N; Tufi R; Apetoh L; Ghiringhelli F; Zitvogel L; Kroemer G Cancer Res; 2007 Sep; 67(17):7941-4. PubMed ID: 17804698 [TBL] [Abstract][Full Text] [Related]
77. Exploiting the Immunogenic Potential of Cancer Cells for Improved Dendritic Cell Vaccines. Vandenberk L; Belmans J; Van Woensel M; Riva M; Van Gool SW Front Immunol; 2015; 6():663. PubMed ID: 26834740 [TBL] [Abstract][Full Text] [Related]